Ascendis Pharma As Stock Profit Margin
A1SN34 Stock | BRL 53.35 1.65 3.00% |
Ascendis Pharma AS fundamentals help investors to digest information that contributes to Ascendis Pharma's financial success or failures. It also enables traders to predict the movement of Ascendis Stock. The fundamental analysis module provides a way to measure Ascendis Pharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Ascendis Pharma stock.
Ascendis |
Ascendis Pharma AS Company Profit Margin Analysis
Ascendis Pharma's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
Competition |
Based on the latest financial disclosure, Ascendis Pharma AS has a Profit Margin of 0.0%. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Biotechnology industry. The profit margin for all Brazil stocks is 100.0% lower than that of the firm.
Ascendis Profit Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Ascendis Pharma's direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Ascendis Pharma could also be used in its relative valuation, which is a method of valuing Ascendis Pharma by comparing valuation metrics of similar companies.Ascendis Pharma is currently under evaluation in profit margin category among its peers.
Ascendis Fundamentals
Return On Equity | -0.67 | |||
Return On Asset | -0.27 | |||
Operating Margin | (15.89) % | |||
Current Valuation | 34.82 B | |||
Shares Outstanding | 57.03 M | |||
Price To Book | 0.90 X | |||
Price To Sales | 1,080 X | |||
Revenue | 7.78 M | |||
Gross Profit | 4.25 M | |||
EBITDA | (364.64 M) | |||
Net Income | (383.58 M) | |||
Book Value Per Share | 8.08 X | |||
Cash Flow From Operations | (417.65 M) | |||
Number Of Employees | 639 | |||
Beta | 0.47 | |||
Market Capitalization | 34.39 B | |||
Total Asset | 1.08 B | |||
Net Asset | 1.08 B |
About Ascendis Pharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Ascendis Pharma AS's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ascendis Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ascendis Pharma AS based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Information and Resources on Investing in Ascendis Stock
When determining whether Ascendis Pharma AS is a strong investment it is important to analyze Ascendis Pharma's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Ascendis Pharma's future performance. For an informed investment choice regarding Ascendis Stock, refer to the following important reports:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Ascendis Pharma AS. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.